Patent ID: 8293241

Claim:
A method of inhibiting relapse tumor growth, the method comprising administering an effective amount of an anti-FGF19 antibody to an individual in need of such treatment, wherein the antibody comprises: (a) a light chain comprising (i) HVR (hypervariable region)-L1 comprising SEQ ID NO:1; (ii) HVR-L2 comprising amino acids 50-56 of SEQ ID NO:4; and (iii) HVR-L3 comprising SEQ ID NO:3; and (b) a heavy chain comprising (i) HVR-H1 comprising SEQ ID NO:5; (ii) HVR-H2 comprising-SEQ ID NO:6; and (iii) HVR-H3 comprising SEQ ID NO:7; wherein the relapse tumor growth is a hepatocellular carcinoma tumor growth or colorectal cancer tumor growth.